TRCT
ARTL icon

Tower Research Capital (TRC)’s Artelo Biosciences ARTL Stock Holding History

Tower Research Capital (TRC)’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.4K Buy
2,826
+2,192
+346% +$10.4K ﹤0.01% 3437
2025
Q4 		$2.32K Buy
+634
New +$4.92K ﹤0.01% 4554
2025
Q3 		– Sell
-149
Closed -$5.93K – 5212
2025
Q2 		$5.93K Sell
149
-68
-31% -$1.26K ﹤0.01% 4139
2025
Q1 		$3.42K Buy
217
+5
+2% +$100 ﹤0.01% 4415
2024
Q4 		$4.05K Sell
212
-76
-26% -$1.53K ﹤0.01% 4530
2024
Q3 		$5.8K Sell
288
-36
-11% -$824 ﹤0.01% 4216
2024
Q2 		$7.8K Buy
324
+54
+20% +$1.35K ﹤0.01% 4425
2024
Q1 		$7.21K Buy
270
+3
+1% +$80 ﹤0.01% 4242
2023
Q4 		$6.72K Buy
267
+148
+124% +$3.64K ﹤0.01% 4705
2023
Q3 		$3.13K Sell
119
-140
-54% -$4.67K ﹤0.01% 5049
2023
Q2 		$9.26K Buy
259
+30
+13% +$1.09K ﹤0.01% 4311
2023
Q1 		$10K Buy
229
+138
+152% +$7K ﹤0.01% 4323
2022
Q4 		$5K Buy
91
+21
+30% +$1.09K ﹤0.01% 4830
2022
Q3 		$4K Buy
70
+52
+289% +$4.19K ﹤0.01% 5223
2022
Q2 		$2K Sell
18
-55
-75% -$5.41K ﹤0.01% 5507
2022
Q1 		$9K Buy
73
+53
+265% +$6.09K ﹤0.01% 4430
2021
Q4 		$3K Sell
20
-17
-46% -$3.36K ﹤0.01% 5414
2021
Q3 		$8K Buy
37
+25
+208% +$6.35K ﹤0.01% 4517
2021
Q2 		$4K Buy
12
+7
+140% +$2.39K ﹤0.01% 4791
2021
Q1 		$2K Buy
+5
New +$2.14K ﹤0.01% 4996
2020
Q3 		– Sell
-3
Closed -$1K – 4808
2020
Q2 		$1K Buy
+3
New +$1K ﹤0.01% 4580
2019
Q4 		– Sell
-1
Closed -$1K – 3503
2019
Q3 		$1K Buy
+1
New +$762 ﹤0.01% 3814
2019
Q2 		– Hold
0
– – – 3640

Other funds holding ARTL

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Tower Research Capital (TRC)'s ARTL Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Artelo Biosciences (ARTL) stake by 346% in Q1 2026, buying an estimated $10.4K and bringing the position to 2,826 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3437.

Tower Research Capital (TRC) first reported a position in ARTL in Q3 2019 and has held it in 22 quarters since. 11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

  • Tower Research Capital (TRC) held 2,826 shares of Artelo Biosciences worth $21.4K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,192 Artelo Biosciences shares in Q1 2026, an estimated $10.4K.
  • Artelo Biosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3437 holding.
  • Tower Research Capital (TRC) first reported a position in Artelo Biosciences in Q3 2019 and has held it in 22 quarters since.
  • 11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.